微血管侵犯在原发性肝癌外科治疗决策中的应用研究进展  

Research progress on the application of microvascular invasion in the decision-making of surgical treatment of hepatocellular carcinoma

作　　者：林为东 宋振顺[2] LIN Weidong;SONG Zhenshun(Hepatobiliary Surgery Department,Taizhou Central Hospital/Taizhou University Hospital,Taizhou 318000;HepatobiliarySurgery Department,Shanghai Tenth People's Hospital/Tenth People's Hospital of Tongji University,Shanghai 200072,China)

机构地区：[1]浙江省台州市中心医院/台州学院附属医院肝胆外科,浙江台州318000 [2]上海市第十人民医院/同济大学附属第十人民医院肝胆外科,上海200072

出　　处：《临床医学研究与实践》2023年第9期195-198,共4页Clinical Research and Practice

摘　　要：微血管侵犯(MVI)是原发性肝癌(HCC)术后复发风险和预后的最重要预测指标之一,是评估HCC术后复发风险和指导治疗决策的重要参考依据。通过优化MVI阳性HCC的根治性外科手术方式和肝切除手术的相应策略,可以显著改善可切除HCC患者的预后。现就MVI在HCC外科治疗决策中应用的最新研究进展作一综述,以明确MVI对可切除HCC外科手术方式和肝切除手术精准优选的作用,以及对降低HCC根治性治疗后复发和改善可切除HCC患者预后的价值。Microvascular invasion(MVI)is one of the most important predictors of postoperative recurrence risk and prognosis of hepatocellular carcinoma(HCC).It is an important reference for evaluating the risk of postoperative recurrence of HCC and guiding treatment decisions.By optimizing the radical surgical approach of MVI-positive HCC and the corresponding strategy of hepatectomy,the prognosis of resectable HCC patients can be significantly improved.Here is to make a review of the latest progress on the application of MVI in the decision-making of surgical treatment of HCC,in order to clarify the role of MVI in the precise optimization of surgical methods and hepatectomy for resectable HCC,and its value in reducing the recurrence of HCC after radical treatment and improving the prognosis of patients with resectable HCC.

关 键 词：微血管侵犯 原发性肝癌 解剖性肝切除 非解剖性肝切除 肝移植 消融治疗 

分 类 号：R735.7[医药卫生—肿瘤]